SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001144204-08-023754
Filing Date
2008-04-23
Accepted
2008-04-23 09:48:38
Documents
1
Period of Report
2008-05-27
Effectiveness Date
2008-04-23

Document Format Files

Seq Description Document Type Size
1 v111411_14a.htm DEF 14A 1002340
  Complete submission text file 0001144204-08-023754.txt   1003819
Mailing Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CA A1 M5J 2G2
Business Address 33 HARBOUR SQ STE 202 TORONTO ONTARIO CANA A1 M5J 2G2 4163642551
GENEREX BIOTECHNOLOGY CORP (Filer) CIK: 0001059784 (see all company filings)

IRS No.: 820490211 | State of Incorp.: DE | Fiscal Year End: 0731
Type: DEF 14A | Act: 34 | File No.: 000-25169 | Film No.: 08770721
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1